Together After Cancer Program for Breast Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how an online self-help program, the Together After Cancer program, can support Latina breast cancer survivors and their partners. The program aims to improve relationship dynamics after cancer treatment, with couples either participating in the program or receiving standard care. It is ideal for Latina breast cancer survivors diagnosed in the past ten years who are in a committed relationship and live in Florida. Participants need internet access and must be willing to engage in the study for about five months. As an unphased trial, this study offers participants a unique opportunity to contribute to innovative support solutions for cancer survivors and their partners.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Together After Cancer program is safe for breast cancer survivors and their partners?
Research has shown that the "Together After Cancer" program is based on a program tested with over 5,000 couples. This indicates that the program is safe and well-received by participants. Previous studies did not report any negative effects, suggesting that participants can join without significant risk. The program aims to help breast cancer survivors and their partners by strengthening their relationships through online content and coaching calls.12345
Why are researchers excited about this trial?
Researchers are excited about the Together After Cancer program because it's a fresh approach to supporting breast cancer survivors and their partners, focusing on romantic relationships, which traditional survivorship care often overlooks. Unlike standard care options that emphasize individual therapy or general support groups, this program offers a tailored, web-based experience that partners can complete at their own pace. The inclusion of scheduled coaching calls ensures couples stay engaged and receive personalized guidance, potentially leading to more meaningful improvements in relationship dynamics. This innovative method could fill a critical gap in survivorship care by addressing intimacy and relationship challenges that are typically left unaddressed.
What evidence suggests that the Together After Cancer program is effective for breast cancer survivors?
Research has shown that the Together After Cancer program, available to participants in this trial, has been used by over 5,000 couples, receiving very positive feedback. An impressive 94% of participants expressed satisfaction with the program, and 97% would recommend it to others. This online self-help program aims to help Latina breast cancer survivors and their partners strengthen their relationships and adjust to life after cancer. It offers tools to enhance closeness and communication, which can be challenging post-cancer. Evidence suggests that couples generally find it helpful in improving their relationship dynamics.12345
Are You a Good Fit for This Trial?
This trial is for Latina/Hispanic breast cancer survivors, aged 18+, who've finished initial treatment within the last five years. Participants must be in a committed relationship for at least six months, willing to follow the study for about 5 months, and have internet access. They must reside in Florida.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Together After Cancer intervention, which includes approximately 8-10 hours of web-based online content delivered over 5-8 weeks, supplemented with up to 100 minutes of coaching calls.
Follow-up
Participants are monitored for changes in relationship functioning, psychological functioning, and quality of life at 2 and 5 months post-randomization.
What Are the Treatments Tested in This Trial?
Interventions
- Together After Cancer
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of South Florida
Lead Sponsor
University of Central Florida
Collaborator
University of Miami Sylvester Comprehensive Cancer Center
Collaborator
AdventHealth
Collaborator
H. Lee Moffitt Cancer Center and Research Institute
Collaborator